Evidence that opioids may have toll-like receptor 4 and MD-2 effects

Chao, 1994, Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression, J. Pharmacol. Exp. Ther., 269, 198 Chen, 1991, Mu receptor binding of some commonly used opioids and their metabolites, Life Sci., 48, 2165, 10.1016/0024-3205(91)90150-A Cui, 2006, Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance, Brain Res., 1069, 235, 10.1016/j.brainres.2005.11.066 Cui, 2008, A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia, Brain Behav. Immun., 22, 114, 10.1016/j.bbi.2007.07.014 Cuschieri, 2007, Acid sphingomyelinase is required for lipid Raft TLR4 complex formation, Surg. Infect., 8, 91, 10.1089/sur.2006.050 Dauphinee, 2006, Lipopolysaccharide signaling in endothelial cells, Lab. Invest., 86, 9, 10.1038/labinvest.3700366 Dobrenis, 1995, Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells, Brain Res., 686, 239, 10.1016/0006-8993(95)00452-V Dziarski, 2001, MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components, J. Immunol., 166, 1938, 10.4049/jimmunol.166.3.1938 El-Hage, 2005, Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat, Glia, 50, 91, 10.1002/glia.20148 Evans, 2007, Ca2+ influx is an essential component of the positive-feedback loop that maintains leading-edge structure and activity in macrophages, Proc. Natl. Acad. Sci. USA, 104, 16176, 10.1073/pnas.0707719104 Gaveriaux-Ruff, 2001, Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity, J. Pharmacol. Exp. Ther., 298, 1193 Gaveriaux-Ruff, 1998, Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene, Proc. Natl. Acad. Sci. USA, 95, 6326, 10.1073/pnas.95.11.6326 Greeneltch, 2004, The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production, Brain Behav. Immun., 18, 476, 10.1016/j.bbi.2003.12.001 Gupta, 2002, Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth, Cancer Res., 62, 4491 Hargreaves, 1988, A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32, 77, 10.1016/0304-3959(88)90026-7 Horvath, 2009, Morphine enhances microglial migration through modulation of P2X4 receptor signaling, J. Neurosci., 29, 998, 10.1523/JNEUROSCI.4595-08.2009 Hoshino, 1999, Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J. Immunol., 162, 3749, 10.4049/jimmunol.162.7.3749 Hutchinson, 2007, Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence and reward, TheScientificWorldJournal, 7, 98, 10.1100/tsw.2007.230 Hutchinson, 2008, Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia, Brain Behav. Immun., 22, 1178, 10.1016/j.bbi.2008.05.004 Hutchinson, 2009, Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast), Brain Behav. Immun., 23, 240, 10.1016/j.bbi.2008.09.012 Hutchinson, 2008, Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia, Brain Behav. Immun., 22, 1248, 10.1016/j.bbi.2008.07.008 Hutchinson, 2008, Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4), Eur. J. Neurosci., 28, 20, 10.1111/j.1460-9568.2008.06321.x Hwang, 2004, Transcriptional regulation of mouse mu opioid receptor gene by PU.1, J. Biol. Chem., 279, 19764, 10.1074/jbc.M400755200 Johnston, 2004, A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine, J. Neurosci., 24, 7353, 10.1523/JNEUROSCI.1850-04.2004 Juni, 2007, Nociception increases during opioid infusion in opioid receptor triple knock-out mice, Neuroscience, 147, 439, 10.1016/j.neuroscience.2007.04.030 Laird, M.H., Rhee, S.H., Perkins, D.J., Medvedev, A.E., Piao, W., Fenton, M.J., Vogel, S.N., 2009. TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J. Leukoc. Biol. Li, 2009, Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2, Biochem. Biophys. Res. Commun., 378, 857, 10.1016/j.bbrc.2008.12.001 Liang, 2006, Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence, Pain, 121, 232, 10.1016/j.pain.2005.12.026 Lipovsky, 1998, Morphine enhances complement receptor-mediated phagocytosis of Cryptococcus neoformans by human microglia, Clin. Immunol. Immunopathol., 87, 163, 10.1006/clin.1998.4518 Liu, 2000, Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation, J. Pharmacol. Exp. Ther., 293, 607 Liu, 2006, A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice, J. Am. Coll. Cardiol., 48, 1871, 10.1016/j.jacc.2006.07.036 Narita, 2004, Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception, Neuroscience, 124, 515, 10.1016/j.neuroscience.2003.11.023 Narita, 2006, Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse, Neuropsychopharmacology, 31, 2476, 10.1038/sj.npp.1301007 Ojaniemi, 2003, Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages, Eur. J. Immunol., 33, 597, 10.1002/eji.200323376 Okun, 2008, Toll-like receptors in neurodegeneration, Brain Res. Rev., 59, 278, 10.1016/j.brainresrev.2008.09.001 Ossipov, 2005, Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure, Biopolymers, 80, 319, 10.1002/bip.20254 Park, 2009, The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex, Nature, 458, 1191, 10.1038/nature07830 Peterson, 1998, The opioid–cytokine connection, J. Neuroimmunol., 83, 63, 10.1016/S0165-5728(97)00222-1 Polakiewicz, 1998, mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control, J. Biol. Chem., 273, 23534, 10.1074/jbc.273.36.23534 Rady, 2001, Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice, J. Pharmacol. Exp. Ther., 299, 659 Raghavendra, 2002, The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats, J. Neurosci., 22, 9980, 10.1523/JNEUROSCI.22-22-09980.2002 Raghavendra, 2004, Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats, Neuropsychopharmacology, 29, 327, 10.1038/sj.npp.1300315 Ruzicka, 1997, The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures, Neuroscience, 79, 517, 10.1016/S0306-4522(96)00669-0 Schilling, 2002, Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages, J. Immunol., 169, 5874, 10.4049/jimmunol.169.10.5874 Shavit, 2005, Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance, Pain, 115, 50, 10.1016/j.pain.2005.02.003 Song, 2001, The involvement of glial cells in the development of morphine tolerance, Neurosci. Res., 39, 281, 10.1016/S0168-0102(00)00226-1 Stefano, 1998, Autoimmunovascular regulation: morphine and anandamide and ancodamide stimulated nitric oxide release, J. Neuroimmunol., 83, 70, 10.1016/S0165-5728(97)00223-3 Takayama, 2005, Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia, J. Neurosci., 25, 430, 10.1523/JNEUROSCI.3170-04.2005 Wang, 2008, Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling, J. Immunol., 180, 3594, 10.4049/jimmunol.180.5.3594 Watkins, 2005, Glia: novel counter-regulators of opioid analgesia, Trends Neurosci., 28, 661, 10.1016/j.tins.2005.10.001 Wu, 2007, Stereoselective action of (+)-morphine over (−)-morphine in attenuating the (−)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse, Eur. J. Pharmacol., 571, 145, 10.1016/j.ejphar.2007.06.012 Wu, 2006, Dextro-Naloxone or levo-naloxone reverses the attenuation of morphine antinociception induced by lipopolysaccharide in the mouse spinal cord via a non-opioid mechanism, Eur. J. Neurosci., 24, 2575, 10.1111/j.1460-9568.2006.05144.x Wu, 2006, Dextro- and levo-morphine atten0uate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice, Eur. J. Pharmacol., 531, 103, 10.1016/j.ejphar.2005.12.012 Wu, 2005, Antianalgesia: stereoselective action of dextro-morphine over levo-morphine on glia in the mouse spinal cord, J. Pharmacol. Exp. Ther., 314, 1101, 10.1124/jpet.105.087130